FOLH1 and hepatocellular carcinoma: Literature indicates that nearly 95% of HCCs express PSMA in tumor neovascularization (32–34); moderate to high levels of PSMA positivity are evident in approximately 80% of HCC cases (35), whereas completely PSMA-negative HCCs constitute a minority (4.1%).